Developing high-yielding, nutritious and climate-resilient crops is vital to safeguard the future of global food production.

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

I get asked a lot about what comes after Donald Trump. Will the Republican Party go back to its conservative roots? Will it continue on a path of absurdity? Will things get better or worse for ...

The bold question-askers at What If examine the challenges of being the last human on Earth. License Revoked! State takes action against local car dealership James Comey strikes back Spectrum launches ...

This is a human-written story voiced by AI. Got feedback? Take our survey. (See our AI policy here.) Artificial intelligence can dash off more than routine emails. It has now written tiny working ...

A badly crushed cranium unearthed decades ago from a riverbank in central China that once defied classification is now shaking up the human family tree, according to a new analysis.Related video above ...

Physicians and researchers gathered in Boston on Wednesday to discuss cutting-edge medical innovations and research against the backdrop of rapid policy changes and major funding cuts by the federal ...

The completion of the Human Genome Project in 2003 marked a turning point in medicine, sparking widespread optimism about a future where diseases could be predicted, prevented, and treated with ...

LAUSANNE, CH AND SAN JOSE, CA / ACCESS Newswire / September 22, 2025 / Logitech International (SIX:LOGN)(Nasdaq:LOGI) today announced the winners of its 3rd annual Future Positive Challenge, a global ...

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced the winners of its 3rd annual Future Positive Challenge, a global call to ...

In 2023, FDA approved one CRISPR/Cas9-based gene therapy to treat sickle cell disease, which marks a significant milestone in the translation of genome editing technologies into clinical therapeutics.